US5166053A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Specimen adequacy control for chlamydia assays
Assignee: Bayer Corp
•
Filing: 1990-02-23
•
Granted: 1992-11-24
•
Expires: 2010-02-23
Abstract
Abstract A method for determining the adequacy of a cervical or urethral test specimen collected for an immunological assay to detect the presence of Chlamydia trachomatis. Cells present in the specimen are disrupted to expose a substance present in or on C. triachomatis that is detectable by immunological reaction. In order to determine if the test specimen contains an adequate amount of the cervical or urethral cell type that serves as a host cell for C. trachomatis, the disrupted specimen is also reacted with an immunological reagent that produces a detectable complex upon specific binding with a substance present in or on columnar epithelial cells. The present invention therefore provides a control reaction that verifies the adequacy of the collected test specimen and thereby increases the confidence that a negative test result for the presence of Chlamydia indicates the absence of a C. trachomatis infection in the patient.
Inventors
- 👤 Edward D. Huguenel
- 👤 William J. Knowles
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-08 14:44
CPC Classifications
G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/53; G01N33/569; G01N33/56911; G01N33/56927; Y; Y10; Y10S; Y10S435/00; Y10S435/961; Y10S435/967; Y10S435/973; Y10S435/975
Claims Analysis
Total Claims: 8
Claim 1
Independent Claim
140 words
In a method for detecting a Chlamydia trachomatis antigen present in a cervical or urethral specimen comprising treating a cervical or urethral specimen to disrupt cells that are present in the said specimen, contacting the resulting specimen mixture with a C. trachomatis antibody reagent which specifically binds to an antigen present in or on C. trachomatis to form a first complex and detecting the complex thus formed, wherein the improvement comprises reacting said disrupted specimen mixture with a columnar epithelial cell antibody reagent which specifically binds with an antigen present in or on the surface of columnar epithelial cells which serve as host cells for C. trachomatis and determining a second complex thus formed as an indication of the presence of an adequate amount of said columnar epithelial cells in said specimen mixture to allow for a valid test result.
Claim 2
Dependent Claim
140 words
In a method for detecting a Chlamydia trachomatis antigen present in a cervical or urethral specimen comprising treating a cervical or urethral specimen to disrupt cells that are present in the said specimen, contacting the resulting specimen mixture with a C. trachomatis antibody reagent which specifically binds to an antigen present in or on C. trachomatis to form a first complex and detecting the complex thus formed, wherein the improvement comprises reacting said disrupted specimen mixture with a columnar epithelial cell antibody reagent which specifically binds with an antigen present in or on the surface of columnar epithelial cells which serve as host cells for C. trachomatis and determining a second complex thus formed as an indication of the presence of an adequate amount of said columnar epithelial cells in said specimen mixture to allow for a valid test result.
Claim 3
Dependent Claim
40 words
The method of claim 1 wherein two separate portions of the disrupted specimen mixture are contacted with the C. trachomatis antibody reagent and the columnar epithelial cell antibody reagent, respectively, and the respective complexes are detected in the separate portions.
Claim 4
Dependent Claim
35 words
The method of claim 1 wherein the disrupted specimen is contacted with both the C. trachomatis antibody reagent and the columnar epithelial cell antibody reagent and the respective complexes are distinguishable in the resulting mixture.
Claim 5
Dependent Claim
153 words
A test kit for detecting Chlamydia trachomatis antigen in a cervical or urethral specimen comprising a C. trachomatis antibody reagent which specifically binds to an antigen present in or on C. trachomatis, wherein the collected specimen is treated to disrupt cells that are present and the resulting disrupted specimen mixture is contacted with the C. trachomatis antibody reagent to form a first complex, and a columnar epithelial cell antibody reagent which specifically binds with an antigen present in or on the surface of columnar epithelial cells to form a second complex, whereby said specimen mixture formed by treatment of said specimen to disrupt cells present therein is tested for the presence of an adequate amount of columnar epithelial cells that serve as host cells for C. trachomatis as an indication of the presence of an adequate amount of said columnar epithelial cells in said specimen mixture to allow for a valid test result.
Claim 6
Dependent Claim
153 words
A test kit for detecting Chlamydia trachomatis antigen in a cervical or urethral specimen comprising a C. trachomatis antibody reagent which specifically binds to an antigen present in or on C. trachomatis, wherein the collected specimen is treated to disrupt cells that are present and the resulting disrupted specimen mixture is contacted with the C. trachomatis antibody reagent to form a first complex, and a columnar epithelial cell antibody reagent which specifically binds with an antigen present in or on the surface of columnar epithelial cells to form a second complex, whereby said specimen mixture formed by treatment of said specimen to disrupt cells present therein is tested for the presence of an adequate amount of columnar epithelial cells that serve as host cells for C. trachomatis as an indication of the presence of an adequate amount of said columnar epithelial cells in said specimen mixture to allow for a valid test result.
Claim 7
Dependent Claim
30 words
The test kit of claim 4 comprising separate reaction sites for contact between the disrupted specimen and said C. trachomatis antibody reagent and said columnar epithelial cell antibody reagent, respectively.
Claim 8
Dependent Claim
35 words
The test kit of claim 4 wherein the specific binding of said C. trachomatis antibody reagent to its antigen is distinguishable from the specific binding of said columnar epithelial cell antibody reagent with its antigen.
References Cited (Backward Citations)
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1995-11-24 | 1996-05-25 | 1996-11-24 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1999-11-24 | 2000-05-25 | 2000-11-24 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2003-11-24 | 2004-05-25 | 2004-11-24 | $7700.00 | Window Closed / Lapsed |